A Partial Volume Effect Correction Tailored for ¹⁸F-FDG-PET Oncological Studies

Table 7

Oncological patients: results of SUV quantification with PVE correction on correlation studies between SUV and prognostic factors (𝑃 is the result of statistical tests).

Patient group	Lesion d (cm)	SUV (g/cc)	𝑃	PVE-corrected SUV (g/cc)	𝑃 after PVE correction
Gastro	2.15 ± 1.17	3.27 ± 1.22 (SRC)	𝑃>0.05	5.57 ± 3.22 (SRC)	𝑃<0.05
	(0.99–6.25)	7.93 ± 5.01 (SC)		9.90 ± 1.91 (SC)
Breast	1.57 ± 0.5	2.28 ± 1.02 (Mib+)	𝑃>0.05	4.52 ± 2.92 (Mib+)	𝑃<0.05
	(1.1–3.2)	7.64 ± 6.08 (Mib−)		9.30 ± 7.40 (Mib−)
Head-neck	1.52±0.5	<10.8 (lymph−)	𝑃>0.05	<13.3 (lymph−)	𝑃<0.05
		>10.8 (lymph+)		>13.3 (lymp+)